Skip to main content
. 2019 Dec 9;12(Suppl 1):21–29. doi: 10.1007/s13193-019-01014-4

Table 1.

Summary of commercially available prognostic tests

Oncotype DX MammaPrint Prosigna EndoPredict Breast Cancer Index CanAssist Breast
No. of genes used 21 70 50 8 7 5 biomarkers
Proliferation genes included Yes Yes Yes Yes No No
Method qPCR DNA microarray NanoString qPCR qPCR IHC
Clinical parameters No No No Tumor size, node status No Tumor size, node status, and tumor grade
Presence of intermediate zone Yes No Yes No No No
Prediction of chemotherapy benefit Yes No No No No Yes